Evidence map›Paper›PMID 26935726›Full record

ArticleJournal of clinical microbiology2016

Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation Unit.

Guillaume Desoubeaux, Manon Dominique, Florent Morio, Rose-Anne Thepault, Claire Franck-Martel, Anne-Charlotte Tellier, Martine Ferrandière, Christophe Hennequin, Louis Bernard, Ephrem Salamé and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06892951 (Phase I/II Safety lead-in Randomized Blind Placebo-controlled Clinical Trial), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06892951 phase1 / phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Phase I/II Safety lead-in Randomized Blind Placebo-controlled Clinical Trial: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia in Adjunction of Conventional Systemic Antifungal Therapy

TypeinterventionalSponsorUniversity Hospital, ToursRan2025 to 2028Enrolled100ConditionsPneumocystis Pneumonia, Pneumocystis Jirovecii Infection, Pneumocystis InfectionsArmsCaspofungin Acetate 50 MG, Physiologic saline
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Trends in the Epidemiology ofJournal of fungi (Basel, Switzerland) · 2023
    Review
  4. Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  5. Article
  6. Pneumocystis pneumonia in liver transplant recipients.American journal of translational research · 2021
    Article
  7. Is Routine Prophylaxis AgainstJournal of clinical medicine · 2020
    Article
  8. Consensus Multilocus Sequence Typing Scheme forJournal of fungi (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Article
  11. Frontiers in microbiology · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. F1000Research · 2017
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guillaume DesoubeauxCHU de Tours, Service de Parasitologie-Mycologie-Médecine Tropicale, Tours, France Université François-Rabelais, CEPR, INSERM U1100/Équipe 3, Faculté de Médecine, Tours, France guillaume.desoubeaux@univ-tours.fr.
Manon DominiqueCHU de Tours, Service de Parasitologie-Mycologie-Médecine Tropicale, Tours, France.
Florent MorioCHU de Nantes, Institut de Biologie, Laboratoire de Parasitologie-Mycologie, Nantes, France Département de Parasitologie et Mycologie Médicale, Université de Nantes, Nantes Atlantique Universités, EA1155-IICiMed, Faculté de Pharmacie, Nantes, France.
Rose-Anne ThepaultUniversité François-Rabelais, Imagerie et Cerveau, INSERM U930/Équipe 2, Faculté de Médecine, Tours, France.
Claire Franck-MartelCHU de Tours, Service de Parasitologie-Mycologie-Médecine Tropicale, Tours, France.
Anne-Charlotte TellierCHU de Tours, Service de Réanimation Chirurgicale, Tours, France.
Martine FerrandièreCHU de Tours, Service de Réanimation Chirurgicale, Tours, France.
Christophe HennequinCHU Saint-Antoine, Laboratoire de Parasitologie & Mycologie, Paris, France Université Pierre et Marie Curie-Paris 6, INSERM UMR-S 945, Paris, France.
Louis BernardUniversité François-Rabelais, CEPR, INSERM U1100/Équipe 3, Faculté de Médecine, Tours, France CHU de Tours, Service de Médecine Interne & Maladies Infectieuses, Tours, France.
Ephrem SalaméCHU de Tours, Service de Chirurgie Digestive, Endocrinienne et Transplantation Hépatique, Tours, France.
Éric BaillyCHU de Tours, Service de Parasitologie-Mycologie-Médecine Tropicale, Tours, France.
Jacques ChandenierCHU de Tours, Service de Parasitologie-Mycologie-Médecine Tropicale, Tours, France Université François-Rabelais, CEPR, INSERM U1100/Équipe 3, Faculté de Médecine, Tours, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over a 5-month period, four liver transplant patients at a single hospital were diagnosed with Pneumocystis jirovecii pneumonia (PCP). This unusually high incidence was investigated using molecular genotyping. Bronchoalveolar lavage fluids (BALF) obtained from the four liver recipients diagnosed with PCP were processed for multilocus sequence typing (MLST) at three loci (SOD, mt26s, and CYB). Twenty-four other BALF samples, which were positive for P. jirovecii and collected from 24 epidemiologically unrelated patients with clinical signs of PCP, were studied in parallel by use of the same method. Pneumocystis jirovecii isolates from the four liver recipients all had the same genotype, which was different from those of the isolates from all the epidemiologically unrelated individuals studied. These findings supported the hypothesis of a common source of contamination or even cross-transmission of a single P. jirovecii clone between the four liver recipients. Hospitalization mapping showed several possible encounters between these four patients, including outpatient consultations on one particular date when they all possibly met. This study demonstrates the value of molecular genotyping of P. jirovecii isolated from clinical samples for epidemiological investigation of PCP outbreaks. It is also the first description of a common source of exposure to a single P. jirovecii clone between liver transplant recipients and highlights the importance of prophylaxis in such a population.

Indexed as

Disease OutbreaksTransplant RecipientsAgedBronchoalveolar Lavage FluidFemaleHumansKidney TransplantationMaleMiddle AgedMolecular EpidemiologyMultilocus Sequence TypingMycological Typing TechniquesPneumocystis cariniiPneumonia, Pneumocystis

Identifiers

PMID26935726
PMCPMC4844736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.